Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA Margin
19.88%
TTM · Period ending:

BIO EBITDA Margin
Latest reported19.88%period ending
Latest reported19.88%period ending
BIO TTM EBITDA Margin (17.89% → 19.88%)
TTM ebitda margin
High-resolution chart · PNG
BIO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 18.4464% | |
| 17.713% | |
| 16.6368% | |
| 16.0296% | |
| 15.523% | |
| 15.451% | |
| 13.8391% | |
| 14.2111% | |
| 13.5058% | |
| 12.37% | |
| 11.79% | |
| 11.1871% | |
| 11.2881% | |
| 11.3423% | |
| 10.8431% | |
| 11.6416% | |
| 12.9529% | |
| 13.6134% | |
| 14.2994% | |
| 14.3653% | |
| 14.2264% | |
| 14.1278% | |
| 14.1957% | |
| 14.4525% | |
| 14.616% | |
| 15.0757% | |
| 15.0577% | |
| 13.0385% | |
| 11.7009% | |
| 10.0681% | |
| 8.1887% | |
| 9.171% | |
| 9.4225% | |
| 7.3044% | |
| 8.6285% | |
| 8.5028% | |
| 8.9692% | |
| 11.461% | |
| 11.0074% | |
| 12.1841% | |
| 11.9472% | |
| 12.2587% | |
| 12.1032% | |
| 11.2463% | |
| 11.4875% | |
| 11.9758% | |
| 32.4301% | |
| -24.8776% | |
| -7.1826% | |
| 12.5488% | |
| 10% | |
| 24.6048% | |
| 21.632% | |
| 17.0435% | |
| 10.2821% | |
| 23.2262% | |
| 18.9399% | |
| 14.403% | |
| 9.3281% | |
| 21.8045% | |
| 17.8947% |